Results 61 to 70 of about 2,830,257 (398)

Real-world effectiveness of eptinezumab in chronic migraine-increase in good days in three subgroups: psychiatric comorbidities, prior subcutaneous anti-calcitonin gene-related peptide therapy, and migraine-associated brain fog. [PDF]

J Headache Pain
Argoff C, Khan FA, Herzog SP, Smith RM, Soni-Brahmbhatt S, Asher D, Awad SF, Grossman SW, Patel F, Buse DC.   +9 more
europepmc   +2 more sources

Metacognition and headache: which Is the role in childhood and adolescence? [PDF]

, 2017
Headache, in particular migraine, is one of the most frequent neurological symptoms in children and adolescents and it affects about 60% of children and adolescents all over the world.
Calderoni, D, Cerutti, R, Faedda, N, Guidetti, V., Natalucci, G, Verdecchia, P   +5 more
core   +2 more sources

Latest clinical recommendations on valproate use for migraine prophylaxis in women of childbearing age. Overview from European Medicines Agency and European Headache Federation [PDF]

, 2018
Migraine is a common and burdensome neurological condition which affects mainly female patients during their childbearing years. Valproate has been widely used for the prophylaxis of migraine attacks and is also included in the main European Guidelines ...
Dogne, Jean-Michel, Garcia Burgos, Juan, Girard, Thomas, Martelletti, Paolo, Straus, Sabine, Vatzaki, Efstratia   +5 more
core   +2 more sources

Chronic Migraine, Comorbidity, and Socioeconomic Deprivation: Cross-Sectional Analysis of a Large Nationally Representative Primary Care Database

Journal of Comorbidity, 2017
Background: Chronic migraine is common but there is limited knowledge on associated comorbidities. Objectives: To examine mental and physical comorbidities in chronic migraine and the influence of socioeconomic status in a large, nationally ...
Gary McLean, Stewart W. Mercer
doaj   +1 more source

Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine

The Journal of Headache and Pain, 2021
Background Galcanezumab, a humanized monoclonal antibody that binds calcitonin gene-related peptide, has demonstrated a significant reduction in monthly migraine headache days compared with placebo. Here, we analyze data from 3 randomized clinical trials
Michael Ament, Kathleen Day, Virginia L Stauffer, Vladimir Skljarevski, Mallikarjuna Rettiganti, Eric Pearlman, Sheena K. Aurora   +6 more
doaj   +1 more source

Neuromodulation [PDF]

, 2016
Neuromodulation is a new promising treatment for headache disorders. It consists of peripheral nerve neurostimulation and central neurostimulation. © 2016, Touch Briefings.
Silberstein, Stephen
core   +2 more sources

The Effect of Psychiatric Comorbidities on Headache‐Related Disability in Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study

Headache, 2020
Objective To examine the influences of depression and anxiety on headache‐related disability in people with episodic migraine or chronic migraine. Background Depression and anxiety are common comorbidities in people with migraine, especially among those ...
R. Lipton, E. Seng, M. Chu, M. Reed, K. Fanning, A. Adams, D. Buse   +6 more
semanticscholar   +1 more source

Is Helicobacter Pylori Associated with a Migraine? [PDF]

, 2017
Objective: To determine whether Helicobacter pylori (H. pylori) is associated with migraine headache. Design: Case-control study. Settings: Local tertiary Hospitals in Cairo, Egypt and in HaferAlbaten, Saudi Arabia.
Ali Radwa A, Mahmoud Mohamed A, Ali Abdelrazak M   +2 more
core   +1 more source

‘Chronic migraine’ is a misnomer

Neurología (English Edition), 2017
las lesiones son extensas o la sintomatología es muy intensase prefiere tratamiento quirúrgico8. En el caso de nuestrapaciente, el tratamiento con amitriptilina y diversos fárma-cos neuromoduladores solamente redujo de forma parcial lasintomatología junto con la presencia de efectos adversosque limitaban la eficacia de los fármacos.
openaire   +3 more sources

Longitudinal Relationship Between Pain and Depression in People With Inflammatory Arthritis: A Narrative Review

Arthritis Care &Research, EarlyView.
As many patients with inflammatory arthritis (IA) have chronic pain, understanding how to best assess and manage pain in IA is a priority. Comorbid depression is prevalent in adults with IA, affecting 15% to 39% of people. Although pain and depression are thought to be associated in IA, this concept is largely based on cross‐sectional data.
Natasha Cox, Saeed Farooq, Helen Twohig, Ian C. Scott   +3 more
wiley   +1 more source